NCT07262619
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07262619
Title EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Eikon Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Morristown Medical Center Morristown New Jersey 07960 United States Details
Memorial Sloan Kettering Cancer Center (MSKCC) New York New York 10022 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Calvary Mater Newcastle Hospital Waratah New South Wales Australia Details
Illawarra Cancer Care Centre (ICCC) Wollongong New South Wales Australia Details
Chris O'Brien Lifehouse (Sydney Cancer Centre) Camperdown Victoria Australia Details
Peninsula and Southeast Oncology (PASO) Medical Frankston Victoria Australia Details
Olivia Newton John Cancer Research Institute Heidelberg Victoria Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field